These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 19212214)

  • 81. Sagittal sinus thrombosis in JAK2-V617F mutation without overt myeloproliferative disorder.
    Bhand PR; Karde SR; Ramesh N
    BMJ Case Rep; 2017 Feb; 2017():. PubMed ID: 28228434
    [TBL] [Abstract][Full Text] [Related]  

  • 82. [ELABORATION AND TREATMENT DECISION IN INCIDENTAL SPLANCHNIC VEIN THROMBOSIS].
    Rozano Gorelick A; Zuckerman E
    Harefuah; 2019 Mar; 158(3):176-179. PubMed ID: 30916505
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Jakking up tumor registry reporting of the myeloproliferative neoplasms.
    Selinger HA; Ma X
    Am J Hematol; 2009 Feb; 84(2):124-6. PubMed ID: 19117021
    [No Abstract]   [Full Text] [Related]  

  • 84. Thrombotic risk factors in nonmalignant and noncirrhotic patients with portal vein thrombosis: need for extensive investigation.
    Kurtcehajic A; Zerem E; Hujdurovic A; Fejzic JA
    Eur J Gastroenterol Hepatol; 2016 Jan; 28(1):116-8. PubMed ID: 26594916
    [No Abstract]   [Full Text] [Related]  

  • 85. Portal vein thrombosis mimicking hypovascular hepatic neoplasm: dynamic MR imaging findings.
    Matsuo M; Kanematsu M; Hoshi H; Kondo H; Tomimatsu H; Manabe T
    AJR Am J Roentgenol; 1999 Oct; 173(4):1060-2. PubMed ID: 10511178
    [No Abstract]   [Full Text] [Related]  

  • 86. Portal hypertension as presenting feature of a myeloproliferative disorder. Diagnosis and therapeutic dilemmas.
    Muller EW; De Wolf JT; Haagsma EB
    Scand J Gastroenterol Suppl; 1993; 200():74-9. PubMed ID: 8016576
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Jak2 mutation expands the thrombophilic panel in children.
    Forest C; Gallo P; Fumarola A; Burnelli R; Suppiej A
    J Thromb Haemost; 2020 Oct; 18(10):2636-2639. PubMed ID: 32654426
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Budd Chiari syndrome and V617F/JAK 2 mutation linked with the myeloproliferative disorders.
    Smira G; Gheorghe L; Iacob S; Coriu D; Gheorghe C
    J Gastrointestin Liver Dis; 2010 Mar; 19(1):108-9. PubMed ID: 20361090
    [No Abstract]   [Full Text] [Related]  

  • 89. Portal cavernoma or chronic non cirrhotic extrahepatic portal vein obstruction.
    Elkrief L; Houssel-Debry P; Ackermann O; Franchi-Abella S; Branchereau S; Valla D; Hillaire S; Dutheil D; Plessier A; Hernandez-Gea V; Bureau C
    Clin Res Hepatol Gastroenterol; 2020 Sep; 44(4):491-496. PubMed ID: 32819872
    [TBL] [Abstract][Full Text] [Related]  

  • 90. [Natural history of portal cavernoma without liver disease. A single centre retrospective study of 32 cases].
    Resseguier AS; André M; Orian Lazar EA; Bommelaer G; Tournilhac O; Delèvaux I; Ruivard M; D'Incan M; Boyer L; Aumaître O
    Rev Med Interne; 2016 Jun; 37(6):394-8. PubMed ID: 26387759
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Portal venous thrombosis associated with JAK 2 mutation in pregnancy - case report.
    Barbosa OA; Andrade TG; de Almeida Sousa MD; Correia JW
    J Obstet Gynaecol; 2021 May; 41(4):659-661. PubMed ID: 33241956
    [No Abstract]   [Full Text] [Related]  

  • 92. Portal or hepatic vein thrombosis as the first presentation of a myeloproliferative disorder in patients with normal peripheral blood counts.
    McNamara C; Juneja S; Wolf M; Grigg A
    Clin Lab Haematol; 2002 Aug; 24(4):239-42. PubMed ID: 12181028
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Clinical problem-solving. Simple and complex.
    Leng S; Nallamothu BK; Saint S; Appleman LJ; Bump GM
    N Engl J Med; 2013 Jan; 368(1):65-71. PubMed ID: 23281978
    [No Abstract]   [Full Text] [Related]  

  • 94. A novel subtype of myeloproliferative disorder? JAK2V617F-associated hypereosinophilia with hepatic venous thrombosis.
    Dasari S; Naha K; Hande M; Vivek G
    BMJ Case Rep; 2013 Aug; 2013():. PubMed ID: 23997080
    [TBL] [Abstract][Full Text] [Related]  

  • 95. [Portal vein thrombosis as an onset form of silent myeloproliferative chronic syndrome].
    Santaeugenia S; Martí S; Maria Ribera J; Millá F
    Med Clin (Barc); 2006 Oct; 127(15):598-9. PubMed ID: 17145021
    [No Abstract]   [Full Text] [Related]  

  • 96. Inflammatory pseudotumor of the mesentery causing portal venous thrombosis and cavernomatous transformation.
    Miyazaki H; Isada A; Ohira K; Masutani M; Okushiba S; Shimizu M; Nishimura M
    Intern Med; 2002 Aug; 41(8):633-7. PubMed ID: 12211532
    [TBL] [Abstract][Full Text] [Related]  

  • 97. A 37-year-old male with extensive cerebral venous thrombosis: Clinicopathological correlation of a rare case.
    Mutreja D; Saxena R; K Tilak TVSVG; Tewari V; Moorchung N; Nandi B
    Indian J Pathol Microbiol; 2018; 61(2):219-224. PubMed ID: 29676361
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Kissing gastric ulcers causing acute pancreatitis and portal biliopathy: what's the link?
    Mensier A; Bounoua F; Beretvas G; Mosoi A; Dardenne S
    JOP; 2013 Nov; 14(6):646-8. PubMed ID: 24216552
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Identification of marker genes including RUNX3 (AML2) that discriminate between different myeloproliferative neoplasms and normal individuals.
    Müller CI; Luong QT; Shih LY; Jones LC; Desmond JC; Kawamata N; Tcherniantchouk O; Liu Q; Ito K; Osato M; Ito Y; Tefferi A; de Vos S; Koeffler HP
    Leukemia; 2008 Sep; 22(9):1773-8. PubMed ID: 18323800
    [No Abstract]   [Full Text] [Related]  

  • 100. Masked polycythaemia vera in a patient with extrahepatic portal venous obstruction.
    Pati HP; Dayal S; Kashyap R; Padhy AK
    Eur J Gastroenterol Hepatol; 1998 Oct; 10(10):883-5. PubMed ID: 9831412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.